Allyson Funk Ally is a former senior director of public affairs at PhRMA focused on advocacy issues for the biopharmaceutical industry. Her expertise includes Medicare, Medicaid, 340B, health reform and more. Prior to PhRMA, her experience included leading health communications for a large membership organization, supporting public affairs clients and working for the governor of Louisiana.
Recent Posts
4 things to think about when choosing your health plan
By Allyson Funk | October 28, 2016
Open enrollment is upon us once again. Whether you are picking a plan through your employer or a health insurance marketplace, whether you are getting coverage for the first time or changing to a...
Read More
ICYMI: Data find provider consolidation increases health care costs
By Allyson Funk | October 26, 2016
There is a growing body of research on the impact of health care provider consolidation on overall health care spending. In case you missed it, a recent issue brief from the National Institute for...
Read More
Medicare Monday: How to switch plans during open enrollment
By Allyson Funk | October 24, 2016
We’ve talked before about the importance of considering options and switching plans during open enrollment. One recent study noted beneficiaries can save an average of $400 to $600 per year by...
Read More
New Study: Substantial rebates negotiated in Medicare Part D
By Allyson Funk | October 12, 2016
A new QuintilesIMS Institute research brief takes a first-of-its-kind look at Part D costs after accounting for rebates across 12 therapeutic classes widely used in Part D. This new report...
Read More
Medicare Monday: New Part D study highlights benefit of switching plans
By Allyson Funk | September 26, 2016
With open enrollment beginning on October 15, it’s important for consumers to have adequate information to make the right decision about their health coverage and whether or not they should stay...
Read More
New Survey: Patients’ share of health care costs continues to grow
By Allyson Funk | September 20, 2016
As we’ve highlighted before, a growing body of research continues to raise red flags about the implications of high cost sharing and patients’ ability to access affordable care – even if they have...
Read More
Medicare Monday: New research reveals Part D coverage is more robust than VA coverage for new, innovative medicines
By Allyson Funk | September 12, 2016
For 10 years, Medicare Part D has successfully provided access to affordable prescription drug coverage to seniors and people living with disabilities thanks to robust competition and negotiation...
Read More
Medicare Monday: Upcoming on the Medicare calendar
By Allyson Funk | September 5, 2016
What is coming up this week in the world of Medicare? Tune in to a couple of interesting happenings.
Read More
Empowering consumers and improving access to important clinical information
By Allyson Funk | August 29, 2016
Even though more Americans are insured than ever before, many are facing insurance barriers that may interfere with a doctor’s prescribed course of treatment and impact their care. We recently...
Read More
Medicare Monday: Concerns still abound about Part B proposal
By Allyson Funk | August 15, 2016
We’ve covered many of the concerns about the government’s overreaching proposal to change Medicare Part B payments and negatively impact seniors’ access to treatment. A lack of patient protections...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
